PMS / PMDD — the 14-day premenstrual hormone storm and a clinical difference 80% of Korean women don't know

PMS vs PMDD — clinical distinction

Both occur in the 14 days before menstruation, but differ in intensity and functional impact:

PMS (Premenstrual Syndrome)

• 90% of reproductive-age women
• Mild physical/emotional symptoms 7–14 days before menstruation
• Breast swelling, bloating, headache, irritability, mood shifts
• Daily function normal
• Naturally subsides within 1–3 days of menstruation onset

PMDD (Premenstrual Dysphoric Disorder)

• 5–8% of reproductive-age women
• Clinical-level depression / anxiety
• Functional impact (work, relationships, self-care)
• Suicidal urges possible (proportional ↑ risk in overall suicide stats)
• Recovers within 1 week of menstruation onset
• Relapses at the same point in the next cycle

Neuroscience — hormone storm

Menstrual cycle hormones:

• Follicular (days 1–14): estrogen ↑, progesterone ↓ → stable mood
• Ovulation (~day 14): both hormones peak
• Luteal (days 15–28): progesterone ↑↑, estrogen variable → mood-shift window
• Menstruation start (day 28): both hormones drop sharply → depression / irritability peak

Key variable = serotonin:

• Estrogen ↑ = serotonin ↑
• Estrogen ↓ (luteal / menstruation) = serotonin ↓
• PMDD patients have higher serotonin sensitivity → stronger reaction to fluctuations

Korean PMDD clinical picture

Korean stats:

• 5–8% of reproductive-age women have PMDD (matches the global average)
• Diagnosis rate in Korea ≈ 15% of actual patients (mostly undiagnosed)
• Average delay to treatment = 7 years
• Comorbidity: depression 38%, anxiety disorders 22%, suicidal urges 14%
• Major impact on work / relationships — 14 days of suffering each month

10 PMDD symptoms

5+ of the following, recurring in the 14 days before menstruation with functional impact, suggest PMDD:

1. Severe depressive mood / hopelessness
2. Strong anxiety / tension
3. Abrupt emotional shifts (tears, irritability)
4. Sustained anger / irritability
5. Reduced interest in daily activities
6. Reduced focus / decision-making
7. Fatigue / low energy
8. Appetite changes / cravings (carbs, sweets)
9. Sleep ↓ or ↑
10. Physical symptoms (headache, abdomen, joint pain)

Diagnosis — diary is core

The single most important PMDD diagnostic tool = a 3-cycle diary. Daily entries:

• Cycle day (1–28)
• Intensity of the 10 symptoms (0–10)
• Daily-function impact (0–10)
• Major events / stressors

Pattern after 3 cycles:

• Symptoms cluster 7–14 days before menstruation
• Drop within 1 week of menstruation onset
• Relapse at the same point next cycle
• → clinical PMDD diagnostic criterion

Smartphone apps (Clue, Flo, Daylio) work. Paper diary is also fine.

Treatment — integrated approach

1) Lifestyle (baseline for all)

• Nutrition: 1,200 mg calcium, 360 mg magnesium, 50–100 mg vitamin B6 daily (clinically validated). Less caffeine, alcohol, sugar (especially in luteal phase)
• Exercise: 30 min aerobic × 5 days/week. PMS/PMDD symptoms ↓ 30–50%
• Sleep: 8 hours. Sleep deprivation amplifies luteal symptoms
• Stress management: meditation, yoga, breathing — intentionally ↑ in luteal phase

2) SSRI (first-line for PMDD)

Strong evidence. SSRIs help 70% of PMDD patients.

2 dosing patterns:

• Continuous — like regular depression treatment. Recommended when depression coexists
• Luteal only — start 14 days before menstruation, stop on menstruation onset (14 days/cycle). Effective for pure PMDD without depression

Drug options:

• Sertraline — 50–100 mg
• Fluoxetine — 20 mg
• Escitalopram — 10–20 mg

Onset — luteal dosing works within 1–2 cycles (faster than the standard 4–6 weeks for general SSRI use).

3) CBT (cognitive behavioral therapy)

Combining with SSRI raises efficacy. Examine luteal-phase cognitive distortions:

• "This is who I am forever" → "this is 14 days"
• "I'm a burden to my family" → "hormones speaking, not me"
• Recognize "decisions in this period aren't trustworthy" → defer big decisions out of luteal phase

4) Hormonal therapy (severe)

• Low-dose oral contraceptives — flatten the cycle. First-line hormonal therapy
• GnRH agonists — pause the cycle itself (severe / drug-resistant)
• Oophorectomy — last-resort option

5) Non-hormonal adjuncts

• Light therapy (SAD lamps) — depression ↓
• Acupuncture — some studies
• Korean herbal medicine (dong quai, peony, etc.) — commonly used in Korea; weaker clinical evidence but helps some patients

At Korean workplaces and in relationships

At work

• PMDD is legally a "women's health" reason — psychiatric documentation can support menstrual leave / half-days
• Partial disclosure to HR/EAP supports negotiating 1–2 rest days per month
• Avoid big presentations / decisions in luteal phase (reschedule when possible)

Family / spouse

• Share "hormonal cycle" information with family — PMDD is not "personality" but hormones
• Avoid big conflicts in luteal phase — postpone decisions/arguments past menstruation
• Have the spouse track the cycle too — awareness reduces conflict
• No "I'm too sensitive" self-criticism — acknowledge hormones

Red flags — see a doctor

• Suicidal urges / self-harm (common in PMDD)
• Luteal-phase daily function ≤30%
• Relationship crisis / divorce consideration
• Rising alcohol / drug use
• Can't go to work / can't go out

1577-0199, psychiatry, OB/GYN immediately.

Korean resources

• Ministry of Gender Equality and Family 1366 — women's crisis line
• 1577-0199 — mental-health crisis
• University-hospital OB/GYN + psychiatry joint clinics
• Korean Society for Women's Health materials
• Online PMDD support groups

Takeaway

• PMS = 90% of women, mild symptoms; PMDD = 5–8%, clinical.
• PMDD neuroscience = elevated serotonin sensitivity, strong reaction to hormone shifts.
• Diagnosis = 3-cycle diary as the basis.
• Treatment: nutrition, exercise, sleep, SSRI, CBT, hormones (severe).
• Luteal-phase SSRI dosing = 14 days/cycle, effective.
• Average 7-year diagnostic delay in Korea — don't romanticize as "mood swings."